Postoperative results of laparoscopic lateral suspension operation: A clinical trials study

Background

Pelvic organ prolapse surgery carries potential risks, and Laparoscopic lateral suspension (LLS) surgery is being performed in increasing numbers with advances in minimally invasive surgery. Our study aims to report the postoperative results of LLS operations.

Patients and Methods

41 patients at POP Q stage 2 and above underwent LLS operations in a tertiary center between 2017 and 2019. Postoperative patients 12 (12-37) months and older were evaluated in terms of anterior and apical compartments.

Results

In our study, laparoscopic lateral suspension (LLS) was applied to 41 patients. The mean age of all patients was 51.45 ± 11.51, and the operation time was 71.13 ± 18.70 min, The mean hospital stay was 1.35 ± 0.4 days. The apical compartment success rate was 78% and the anterior compartment success rate was 73%. In terms of patient satisfaction, 32 (78.1%) patients were satisfied, While 37 (90.1%) patients did not have abdominal mesh pain, 4 (9.9%) patients had mesh pain. Dyspareunia was not observed.

Conclusions

Laparoscopic lateral suspension in pop surgery; Considering the success rate below expectation, some patient groups can be applied as an alternative surgical method.

Comparison of Perinatal, Newborn, and Audiometry Results of COVID-19 Pregnant Women

OBJECTIVE

There are studies on the perinatal outcomes of COVID-19, but the audiometric effects of the maternal immune system against COVID-19 in the newborn are not clear. In this study, we aimed to investigate the relationship between the perinatal outcomes of COVID-19 positive pregnant women and the audiological outcomes of newborns.

MATERIALS AND METHODS

This retrospective, single-center cohort study was conducted with 65 polymerase chain reaction (PCR) positive pregnant women and newborns and 66 normal pregnant women and newborns who were admitted between January 2020-December 2021. Pregnancy data, perinatal outcomes, and newborn hearing test results of pregnant women and newborns were recorded and compared.

RESULTS

A total of 131 patients were enrolled in the study. The number of normal pregnant women was 66 (50.4%) and the number of pregnant women who had COVID-19 disease was 65 (49.6%). In general, gestational week, age, parity, biochemical parameters, duration of hospital stay, week of delivery, fetal weight, and apgar scores were compared between pregnant women with COVID-19 and normal. White blood cell (WBC), neutrophil, aspartate aminotransferase (AST), and C-reactive protein (CRP) parameters were found to be significantly higher, and lymphocyte and neutrophil/lymphocyte (N/L) ratios were significantly lower (p < 0.05). There was no statistically significant difference between the two groups (χ ²=0.001; p = 1,000). The normal delivery status, the normal delivery rate in patients with COVID-19 was found to be statistically significantly higher than the cesarean section delivery status (p = 0.012). In the statistical comparison between the COVID-19 and normal pregnant groups in the cesarean section group, the gestational week, delivery week, and apgar1 scores of the pregnant women with COVID-19 were found to be significantly higher. There was no statistically significant difference between the distributions of the rate of infants with hearing impairment in the comparison with hearing tests in pregnant women with COVID-19 (n=1) and normal pregnant women (n=1) (χ ²=0.001; p = 1,000).

CONCLUSION

Although the negative effects of COVID-19 on pregnancy outcomes are rare, it was determined that there was no increased audiological risk factor, and the most important predictor of COVID-19 was lymphopenia.

Protein-9 (CTRP9) levels associated with C1q tumor necrosis factor in obese preeclamptic, non-obese preeclamptic, obese and normal pregnant women

AIM

The incidence of obesity and preeclampsia is increasing more and more all over the world. Inflammation and endovascular dysfunction play an important role in the etiopathogenesis of preeclampsia. Obesity has been reported to contribute to the development of preeclampsia by developing a low-grade inflammatory environment and adversely affecting maternal endothelial function. Studies on the relationship between obesity and preeclampsia and how this relationship contributes to endothelial dysfunction continue. The complement C1q tumor necrosis factor-associated protein (CTRP) family (CTRP1-15) secreted from the adipose tissue is a new generation adipokine family with important functions in the immunomodulatory, anti-inflammatory, apoptosis, autoimmunity, vascular system, glucose and lipid metabolism in the body. In recent years, CTRP9, a member of this family, has been shown to have a strong vasorelaxation effect with the Adiponectin Receptor-1/AMPK/eNOS/Nitric Oxide Signaling Pathway. The study aims to find out the role of CTRP9, an adipocytokine, in the pathogenesis of obesity and preeclampsia.

MATERIAL AND METHOD

The CTRP9 levels were measured by the enzyme-linked immunosorbent assay (ELISA) in 40 obese preeclamptic, 40 non-obese preeclamptic, 40 obese pregnant women and 40 normal BMI (Body mass index) pregnant women.

RESULTS

The CTRP9 level of the obese preeclampsia group was found to be lower compared to the non-obese preeclampsia, obese pregnant and normal BMI pregnant control groups (p < .001). The obese preeclampsia group had higher systolic and diastolic blood pressure values compared to the non-obese preeclampsia group (p < .001). There was no difference between the CTRP9 levels of the normal BMI and non-obese preeclampsia groups (p > .05). The serum CTRP9 levels were inversely correlated with age, BMI, blood pressure, and aspartate aminotransferase (AST) (p < .001).

CONCLUSION

Obesity causes a decrease in CTRP9 levels and contributes to the pathogenesis of preeclampsia with adverse effects on the vascular and placental system. Serum CTRP9 levels in pregnant women help identify pregnancies at risk in terms of obesity and preeclampsia.

Culdotomy in laparoscopic myomectomy and its limits

OBJECTIVE

To examine the results and limits of culdotomy method for removal of myoma from the abdomen while preserving its integrity in laparoscopic myomectomy. To determine if this is a good option for tissue extraction.

DESIGN

Retrospective analysis of data collected prospectively.

SETTING

A gynecology and obstetrics training and research hospital.

PATIENTS

A total of 102 patients who underwent laparoscopic myomectomy with culdotomy for tissue extraction.

RESULTS

A total of 102 patients underwent laparoscopic myomectomy between September 2017 and April 2019, and tissues were taken from the abdomen by culdotomy. The mean myoma diameter was 7.7 ± 2.4 cm (4-15 cm) and the mean weight was 161 ± 120 g (20-602 g). The mean duration of surgery was 95 ± 41 min (36-214 min). All myomas were extracted with preservation of their integrity, except in 2 patients. In 87 patients, the myoma was less than 10 cm, and all myomas in this group could be easily extracted from the vagina. The myoma was between 11 and 13 cm in 13 patients. Of these, 8 were extracted without difficulty, 5 could barely be extracted, and superficial vaginal lacerations occurred in 4 of these patients. Due to the inability to extract myomas intact in 2 patients (14 and 15 cm), vaginal mechanical morcellation was performed. In terms of vaginal births, 34 patients (33.3 %) had never had vaginal births, and 68 patients (66.7 %) had a history of vaginal birth. The largest myoma extracted from a woman who had not given birth was 12 cm (345 g). The largest myoma extracted from a woman who had given birth was 13 cm (490 g). None had major complications. No signs of infection were detected on the 7th and 30th postoperative days, and no operative dyspareunia was detected at 6-month follow-up.

CONCLUSION

In the present study, it was seen that myomas up to 13 cm (490 g) in multiparous and 12 cm (350 g) in nulliparous could be removed from the culdotomy while maintaining their integrity. Culdotomy is a safe, inexpensive and effective method for myoma extraction.

Concurrent primary repair of obturator nerve transection during pelvic lymphadenectomy procedure via laparoscopical approach

•

Laparoscopic early stage nerve repair is a feasible method in gynecological surgery.

•

Early nerve repair, short-term clinical and long-term neurological consequences are usually curative.

•

In laparoscopic gynecologic malignancy surgery, laparoscopic management of complications is a minimally invasive procedure.

Introduction

Obturator nerve is barely injured during gynecological surgeries. The risk for obturator nerve injury is increased during pelvic lymphadenectomy procedures of gynecological malignancies. In case of any obturator nerve injury, surgical management involve laparoscopic approaches suchas end-to-end anastomosis in very early period.

Case

A 63-year-old woman, with G3P3, presented with the complaint of abnormal uterine bleeding. She was diagnosed with stage IA endometrial adenocarcinoma. obturator nerve was transected during obturator lymph node dissection in the right side during retroperitoneal lymph node dissection. Subsequently end-to-end anastomosis of the thermally injured areas was performed by epineural sutures. Any significant loss of functions in adductor muscle wasn't observed in the postoperative period. Likewise, any permanent neurological finding wasn't developed at the end of postoperative 6th month.

Discussion

During pelvic lymphadenectomy; obturatory nerve, especially the proximal part, should be concerned. Early intraoperative repair should be performed in case of possible nerve injuries.

Conclusion

Immediate laparoscopic repair is possible in full-thickness injury of obturator nerve, occurred in a gynecological surgery and results with rapid and complete neurological recovery.